Status:
COMPLETED
Efficacy of Jobelyn™ Consumption on Hemoglobin Levels in a Borderline Anemic Population
Lead Sponsor:
Natural Immune Systems Inc
Conditions:
Anemia
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to evaluate the timing and magnitude of improvements to red blood cell health associated with consumption of Jobelyn™.
Detailed Description
From past history, case studies in Nigeria, as well as testimonials from all over the world, have shown a robust increase in hemoglobin within a few weeks in people with serious cases of anemia presen...
Eligibility Criteria
Inclusion
- 18-65 year old people of either gender
- Borderline anemic (This is compensated for altitude of study location):
- Hemoglobin level at or below 13.5 g/dL(women)
- Hemoglobin level at or below 15.5 g/dL(men)
Exclusion
- Known diagnosis with pernicious or other megaloblastic anemias, aplastic, sickle cell, thalassemia, autoimmune hemolytic anemias;
- Known diagnosis with Hashimoto's Disease;
- Known chronic kidney disease;
- Rheumatoid arthritis;
- Splenectomy;
- Serious active illness within past 12 months;
- Active cancer and/or chemotherapy within the last 12 months;
- Major surgery during past 8 weeks;
- Scheduled surgery during study;
- Received blood transfusion during the past 8 weeks;
- Having donated blood for 6 weeks prior to study, or planning to donate blood during the 8 week study;
- Distance athlete;
- Unable to commit to staying on a constant regimen of medication and supplements for the duration of the study, with the exception of changes to medication needed for optimal care;
- Changes to prescription medication within 2 weeks before starting the study;
- Participation in other clinical trials during the month before this study begins;
- Participating in other clinical trials during this study;
- Current use of any dietary supplements that may affect hemoglobin levels; Vitamin B12 (over 500 mcg), Iron (over 100mg), or any other dietary supplement that, in the opinion of the investigator, may affect hemoglobin levels;
- Currently experiencing intense stressful events/ life changes that would negatively affect compliance;
- Previous major gastrointestinal surgery (absorption of test product may be altered) (minor surgery is not a problem, including appendix and gallbladder removal);
- Females of child-bearing potential: Pregnant, nursing, or trying to become pregnant;
- Food allergies related to sorghum or rice.
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT01828060
Start Date
April 1 2013
Last Update
September 25 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NIS Labs
Klamath Falls, Oregon, United States, 97601